Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron for late PONV after breast surgery
NCT05326360Phase 4Completed
- Sponsor
- Pusan National University Hospital
- Start
- Dec 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramosetron in postoperative nausea and vomiting (PONV), sponsored by Pusan National University Hospital. Started Dec 2020; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05326360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326360.